References
- Hospice Action Network. Current State of the Hospice Community. 2013. http://hospiceactionnetwork.org/linked_documents/get_informed/policy_resources/CurrentStateofHospice_Nov2013.pdf. Accessed May 11, 2017.
- Medicare Payment and Advisory Commission (MEDPAC) Hospice services: Report to the Congress: Medicare Payment Policy. March 2018. http://www.medpac.gov/docs/default-source/reports/mar18_medpac_ch12_sec.pdf?sfvrsn=0. Accessed June 5, 2018.
- Lam YW, Lam A, Macy B. Pharmacokinetics of Phenobarbital in Microenema Via Macy Catheter Versus Suppository. J Pain Symptom Manage. 2016;51(6):994–1001.
- Davis MP, Walsh D, LeGrand SB, Naughton M. Symptom control in cancer patients: the clinical pharmacology and therapeutic role of suppositories and rectal suspensions. Support Care Cancer. 2002;10(2):117–138. doi:10.1007/s00520-001-0311-6.
- de Boer AG, Moolenaar F, de Leede LG, Breimer DD. Rectal drug administration: clinical pharmacokinetic considerations. Clin Pharmacokinet. 1982;7(4):285–311. doi:10.2165/00003088-198207040-00002.
- van Hoogdalem E, de Boer AG, Breimer DD. Pharmacokinetics of rectal drug administration, Part I. General considerations and clinical applications of centrally acting drugs. Clin Pharmacokinet. 1991;21(1):11–26. doi:10.2165/00003088-199121010-00002.
- Warren DE. Practical use of rectal medications in palliative care. J Pain Symptom Manage. 1996;11(6):378–387.
- Franken LG, de Winter BC, van Esch HJ, et al. Pharmacokinetic considerations and recommendations in palliative care, with focus on morphine, midazolam and haloperidol. Expert Opin Drug Metab Toxicol. 2016;12(6):669–680. doi:10.1080/17425255.2016.1179281.
- Franken LG, Mathot RAA, Masman AD, et al. Population pharmacokinetics of haloperidol in terminally ill adult patients. Eur J Clin Pharmacol. 2017;73(10):1271–1277.